| Bioactivity | Urease-IN-13 (compound d8) is an inhibitor of urease with an IC50 value of 1.21 μM. Urease-IN-13 has been studied in the context of infectious gastritis and gastric ulcers[1]. |
| Invitro | Urease-IN-13 (250 μg/mL) 在 HepG2、SGC-7901、K562 和 L-02 细胞中的细胞毒性较低，这些细胞的存活率均超过 87%[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Urease-IN-13 相关抗体: |
| Formula | C19H17N3O5 |
| Molar Mass | 367.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wang YN, et al. Synthesis and biological evaluation of triazolones/oxadiazolones as novel urease inhibitors. Bioorg Med Chem. 2024;102:117656. |